Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Christina, Alamara"'
Effects of taxane-based chemotherapy on inhibin B and gonadotropins as biomarkers of spermatogenesis
Autor:
Christina Alamara, Laura Giza, Konstantinos N. Syrigos, Eleftherios Chatzidarellis, Nektaria Makrilia, Efstratios Georgiadis
Publikováno v:
Fertility and Sterility. 94:558-563
Objective To assess the effects of taxane-based chemotherapy on the male reproductive axis, and, therefore, its impact on spermatogenesis and fertility. Design Controlled clinical study. Setting Patients with cancer in an academic research environmen
Autor:
Eleni M. Karapanagiotou, Evangelos Terpos, Ioannis Gkiozos, Aris Polyzos, Kostas N. Syrigos, Christina Alamara, Kalliopi D. Dilana
Publikováno v:
Medical Oncology. 27:332-338
The aim of this study was to investigate several bone markers in Non-Small Cell Lung (NSCLC) and Small Cell Lung (SCLC) patients experiencing or not secondary bony disease. Fasting serum levels of bone formation, bone resorption, and osteoclastogenes
Autor:
Ekaterini Syrigou, Eleni M. Karapanagiotou, Paraskevi Boura, Christina Alamara, Kostas N. Syrigos, Muhammad Wasif Saif
Publikováno v:
Clinical Colorectal Cancer. 8:106-109
Background We recorded the epidemiologic and clinical features of hypersensitivity reactions (HSRs) to oxaliplatin in colorectal cancer (CRC) patients in order to provide information on the management of these patients. We also developed a desensitiz
Autor:
Christina Alamara, Eleni M. Karapanagiotou, Konstantinos N. Syrigos, Kalliopi D. Dilana, Adrianni Charpidou, Ifigeneia A. Tzannou, Ioanna Christakopoulou, Evangelos Georgiou
Publikováno v:
American Journal of Clinical Oncology. 30:503-506
Objectives: The prognosis of patients with small cell lung cancer (SCLC) is dismal with a median survival not exceeding 18 months. For the fact that the tumor stage remains the most significant prognostic factor, efforts have been made to improve its
Autor:
Sotirios Tsimpoukis, Andriani Charpidou, Kostas N. Syrigos, Christina Alamara, Ilias Nikolaidis, Nektaria Makrilia, Maria Ralli, Anastasia Kotanidou, Ioannis Tourkantonis
Publikováno v:
American journal of clinical oncology. 34(1)
The combinations of cisplatin-pemetrexed and cisplatin-gemcitabine are considered the standard systemic therapy for malignant pleural mesothelioma (MPM), which is a rapidly progressive tumor. The purpose of the present study is to evaluate the effica
Autor:
Elias, Kotteas, Christina, Alamara, Maria, Kiagia, Kosmas, Pantazopoulos, Anastasios, Boufas, Aspasia, Provata, Adrianni, Charpidou, Konstantinos N, Syrigos
Publikováno v:
Anticancer research. 28(1B)
Zoledronic acid (Zometa, Novartis, Basel, Switzerland) is a new generation of bisphosphonates (BPs) with demonstrated clinical benefit in breast and prostate cancer patients with bone metastases. The safety and efficacy of intravenous zoledronic acid
Autor:
Konstantinos N. Syrigos, Michael Lykourinas, Christine C. Maurer, Christina Alamara, Eleni M. Karapanagiotou, I. Tourkantonis, Vasilia Xyla, Hardev Pandha
Publikováno v:
European journal of internal medicine. 19(7)
A 29-year-old female was investigated for a consistent lumbar and left lateral abdominal pain. Physical examination and laboratory screening tests were normal. However, abdominal ultrasound (US) and a renal computer tomography (CT) scan showed a hyp
Autor:
Adrianni, Charpidou, Marianthi, Fotinou, Christina, Alamara, Patra, Kalkandi, Dinna, Tiniakou, Konstantina, Alexopoulou, Manolis, Merikas, Kostas N, Syrigos
Publikováno v:
In vivo (Athens, Greece). 21(1)
Two cases of endoluminar/endobronchial metastases (EEM) from a secondary extrathoracic tumour are reported. The patients, eight years after the curative treatment of colorectal adenocarcinoma, were examined exhibiting pulmonary symptoms with radiolog
Autor:
Adrianni, Charpidou, Eleftherios P, Hatzidarellis, Christina, Alamara, Kaliopi, Dilana, Kosmas, Pantazopoulos, Elias, Kotteas, Niki, Georgatou, Konstantinos N, Syrigos
Publikováno v:
In vivo (Athens, Greece). 20(4)
The aim of the present study was to evaluate the efficacy of Pegylated Liposomal Doxorubicin (Caelyx) combined with Sandostatin LAR as salvage treatment of small cell lung cancer (SCLC) in platinum-pretreated patients.Nine pretreated patients (median
Autor:
Konstantinos N, Syrigos, Ioannis, Dannos, Georgios, Dionellis, Ioannis, Bofos, Christina, Alamara, Ekaterini, Dimakou, Grigorios, Stratakos, Spyros, Papiris
Publikováno v:
Anticancer research. 25(5)
The standard treatment for advanced non-small cell lung cancer (NSCLC) currently consists of platinum-based, combination chemotherapy of limited efficacy and possible toxicity. The bi-weekly administration of docetaxel and gemcitabine for advanced NS